Profile data is unavailable for this security.
Mergers & acquisitions
Acquired company | NOVO B:CPH since announced | Transaction value |
---|---|---|
Cardior Pharmaceuticals GmbH | -17.90% | 1.11bn |
Catalent Inc-Manufacturing Sites Portfolio(3) | -6.78% | -- |
Elan Drug Technologies (DNU>16Sep2011 now 01781A) | 8.43% | 92.42m |
Alkermes PLC-Development & Manufacturing Facility | 8.43% | 92.50m |
Data delayed at least 15 minutes, as of Nov 22 2024 10:42 GMT.